ARA-290 (Cibinetide), single vial

Erythropoietin-derived innate repair receptor agonist

ARA-290 (Cibinetide)

Erythropoietin-derived innate repair receptor agonist. Supplied for laboratory research use only.

  • Erythropoietin-derived peptide (cibinetide); reached real Phase 2 trials
  • Holds FDA Orphan Drug and Fast Track status -- not approval
  • Sponsor has since closed; no active IND remains
  • Supplied for laboratory research use only. Not for human or veterinary use.
$239.99$359.97 Save 33%
Every vial 10 mg
Choose your supply
Most Popular
Best Value
In stock, ready to ship

90-Day Money-Back Guarantee

Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.

Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.

What it is
CompoundARA-290 (Cibinetide), also designated Cibinetide
ClassErythropoietin-derived innate repair receptor agonist
FormLyophilised powder, supplied in a vial
OriginatorAraim Pharmaceuticals; the sponsor has since closed
Development status

ARA-290 (Cibinetide) is not approved by the FDA for any indication.

Reached Phase 2 human trials and holds FDA Orphan Drug and Fast Track designations for neuropathic pain in sarcoidosis. Neither designation is an approval. The originating sponsor has closed and no active Investigational New Drug application exists.

Shipping & returns
ReturnsNinety days from delivery. Contact us and we will refund the purchase price.
ARA-290 (Cibinetide) $239.99

The specifics

The details, if you want them.

DeveloperAraim Pharmaceuticals (sponsor has since closed)
Also known asCibinetide
ClassErythropoietin-derived innate repair receptor agonist
Amino acids11
Trial phasePhase 2/2b (not advanced to Phase 3)
FormLyophilised powder
Receptor target(s)Innate repair receptor (a heterodimer of the erythropoietin receptor and CD131, distinct from the classical erythropoietin receptor that drives red blood cell production)

Development

Where it is up to.

Reached Phase 2/2b human trials and holds FDA Orphan Drug and Fast Track designations for one indication — designations, not approvals. Its sponsor has since closed.

Questions

The questions people actually ask.

What is ARA-290?
A synthetic 11-amino-acid peptide derived from erythropoietin, also called cibinetide, engineered to act on a distinct receptor from the one that drives red blood cell production.
Is ARA-290 approved by the FDA?
No. It reached Phase 2/2b human trials and holds FDA Orphan Drug and Fast Track designations for one indication, but its originating sponsor has since closed.
What does "Research Use Only" mean?
Research Use Only means exactly that: intended for laboratory and research settings only, not for human or animal use, consumption, diagnosis, treatment, cure, or prevention of any disease.
How is ARA-290 supplied?
As a vial of lyophilised (freeze-dried) powder, sold for laboratory and research use only.
What is your refund policy?
Ninety days from delivery. If you decide against it inside that window, contact hello@getmrpeps.com and we will refund the purchase price. Damaged or incorrect orders are replaced or refunded regardless.